Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Comparative Study

Meta-Analysis

Systematic Review

Clinical Trial, Phase II

Case Reports

Randomized Controlled Trial

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2024

2023

2021

2019

2018

2016

2014

2012

2011

2009

2005

2004

2002

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Receptor, trkA""[mesh_terms]

16 Results

Searching titles within these results

TRK oncogenes in papillary thyroid carcinoma.

Angela Greco, Emanuela Roccato, Marco A Pierotti

Cancer treatment and research 2005;122():207-19

Full Text

Influential Serum Kinases (Non-sFlt-1) and Phosphatases in Preeclampsia-Systemic Review and Metanalysis.

Karla Cecilia Marrufo-Gallegos, Jose Rafael Villafán-Bernal, Salvador Espino-Y-Sosa, Guadalupe Estrada-Gutierrez, Iris Paola Guzmán-Guzmán, Raigam Jafet Martinez-Portilla, Johnatan Torres-Torres

International journal of molecular sciences 2023;24(16):12842

Free Full Text

Abstract

Phenotypic heterogeneity of intellectual disability in patients with congenital insensitivity to pain with anhidrosis: A case report and literature review.

Zhenlei Liu, Jiaqi Liu, Gang Liu, Wenjian Cao, Sen Liu, Yixin Chen, Yuzhi Zuo, Weisheng Chen, Jun Chen, Yu Zhang, Shishu Huang, Guixing Qiu, Philip F Giampietro, Feng Zhang, Zhihong Wu, Nan Wu

The Journal of international medical research 2019;46(6):2445-2457

Free Full Text

Abstract

Efficacy and safety of NTRK inhibitors in patients with NTRK fusion-positive lung and thyroid cancers.

Alexander Drilon, David S Hong, Lori J Wirth

Clinical advances in hematology & oncology : H&O 2024;22 Suppl 5(6):1-20

Full Text

Abstract

The inorganic perspective of nerve growth factor: interactions of Cu2+ and Zn2+ with the N-terminus fragment of nerve growth factor encompassing the recognition domain of the TrkA receptor.

Alessio Travaglia, Giuseppe Arena, Roberto Fattorusso, Carla Isernia, Diego La Mendola, Gaetano Malgieri, Vincenzo G Nicoletti, Enrico Rizzarelli

Chemistry (Weinheim an der Bergstrasse, Germany) 2011;17(13):3726-38

Full Text

Abstract

Nerve growth factor as an important possible component of novel therapy for cancer, diabetes and cardiovascular diseases.

Karol P Steckiewicz, Ewelina Barcińska, Michał Woźniak

Cellular and molecular biology (Noisy-le-Grand, France) 2018;64(9):16-23

Full Text

Abstract

Gain of function mutations of RTK conserved residues display differential effects on NTRK1 kinase activity.

Claudia Miranda, Giuseppe Zanotti, Sonia Pagliardini, Carola Ponzetto, Marco A Pierotti, Angela Greco

Oncogene 2002;21(54):8334-9

Full Text

Abstract

Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A Review.

Rossella Elisei, Robert Haddad, Ana O Hoff, Zhiyan Liu, Fabian Pitoia, Giancarlo Pruneri, Peter M Sadow, Fernando Soares, Andrew Turk, Michelle D Williams, Lori J Wirth, Maria E Cabanillas

JAMA oncology 2023;9(8):1132-1141

Full Text

Abstract

Pronerve growth factor induces angiogenesis via activation of TrkA: possible role in proliferative diabetic retinopathy.

Sally L Elshaer, Mohammed A Abdelsaid, Ahmad Al-Azayzih, Parag Kumar, Suraporn Matragoon, Julian J Nussbaum, Azza B El-Remessy

Journal of diabetes research 2014;2013():432659

Free Full Text

Abstract

Developments in autonomic research: a review of the latest literature.

Vaughan G Macefield

Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2009;19(4):193-6

Full Text

Abstract

Anticarcinogenic activities of sulforaphane are influenced by Nerve Growth Factor in human melanoma A375 cells.

Paola Arcidiacono, Anna Maria Stabile, Francesco Ragonese, Alessandra Pistilli, Stefano Calvieri, Ugo Bottoni, Andrea Crisanti, Roberta Spaccapelo, Mario Rende

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2018;113():154-161

Full Text

Abstract

U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors.

Kyriakos P Papadopoulos, Erkut Borazanci, Alice T Shaw, Ryohei Katayama, Yuki Shimizu, Viola W Zhu, Thomas Yang Sun, Heather A Wakelee, Russell Madison, Alexa B Schrock, Giorgio Senaldi, Naoki Nakao, Hiroyuki Hanzawa, Masaya Tachibana, Takeshi Isoyama, Kenji Nakamaru, Chenhui Deng, Meijing Li, Frank Fan, Qinying Zhao, Yanfei Gao, Takashi Seto, Pasi A Jänne, Sai-Hong Ignatius Ou

Clinical cancer research : an official journal of the American Association for Cancer Research 2021;26(18):4785-4794

Full Text

Abstract

DHA, EPA and their combination at various ratios differently modulated Aβ-induced neurotoxicity in SH-SY5Y cells.

Yong-Ping Zhang, Richard E Brown, Ping-Cheng Zhang, Yun-Tao Zhao, Xiang-Hong Ju, Cai Song

Prostaglandins, leukotrienes, and essential fatty acids 2019;136():85-94

Full Text

Abstract

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.

Milo Frattini, Cristina Ferrario, Paola Bressan, Debora Balestra, Loris De Cecco, Piera Mondellini, Italia Bongarzone, Paola Collini, Manuela Gariboldi, Silvana Pilotti, Marco A Pierotti, Angela Greco

Oncogene 2004;23(44):7436-40

Full Text

Abstract

Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.

David Roblin, Gil Yosipovitch, Brent Boyce, John Robinson, James Sandy, Valentina Mainero, Ro Wickramasinghe, Uma Anand, Praveen Anand

Acta dermato-venereologica 2016;95(5):542-8

Free Full Text

Abstract

Results: 1 – 15 / 16

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Receptor, trkA""[mesh_terms]

TRK oncogenes in papillary thyroid carcinoma.

Influential Serum Kinases (Non-sFlt-1) and Phosphatases in Preeclampsia-Systemic Review and Metanalysis.

Phenotypic heterogeneity of intellectual disability in patients with congenital insensitivity to pain with anhidrosis: A case report and literature review.

Efficacy and safety of NTRK inhibitors in patients with NTRK fusion-positive lung and thyroid cancers.

The inorganic perspective of nerve growth factor: interactions of Cu2+ and Zn2+ with the N-terminus fragment of nerve growth factor encompassing the recognition domain of the TrkA receptor.

Nerve growth factor as an important possible component of novel therapy for cancer, diabetes and cardiovascular diseases.

Gain of function mutations of RTK conserved residues display differential effects on NTRK1 kinase activity.

Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A Review.

Pronerve growth factor induces angiogenesis via activation of TrkA: possible role in proliferative diabetic retinopathy.

Developments in autonomic research: a review of the latest literature.

Anticarcinogenic activities of sulforaphane are influenced by Nerve Growth Factor in human melanoma A375 cells.

U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors.

DHA, EPA and their combination at various ratios differently modulated Aβ-induced neurotoxicity in SH-SY5Y cells.

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.

Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.

Results for
""Receptor, trkA""[mesh_terms]